GE HealthCare (GEHC) announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL at the European Society for Therapeutic Radiology and Oncology 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy. GE HealthCare intends to add Spectronic Medical AB’s software offering to its radiation oncology portfolio. Spectronic is headquartered in Helsingborg, Sweden, and is focused on advanced image analysis solutions which are designed to improve clinical workflows and enhance patient care in radiation oncology.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare participates in a conference call with JPMorgan
- Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
- GE HealthCare price target lowered to $89 from $103 at Wells Fargo
- GE Healthcare Technologies Inc: Strong Growth Potential Amid Challenges with Positive Outlook
- Neutral Rating on GE Healthcare Amid Tariff Challenges and Strong Performance